Tag:
Cellceutix
Latest Headlines
Latest Headlines
Cellceutix reports preclinical progress on cancer therapy
Beverly, MA-based Cellceutix says that it has observed promising results from its preclinical cell studies on Kevetrin, a potential therapy targeting drug-resistant cancer cells. Researchers for the
Formatech fills for Phase I Cellceutix study
Drug formulator Formatech of Andover, MA, will prep Kevetrin, a candidate for the treatment of drug-resistant cancers, for a Cellceutix Phase I study. The small-molecule substance will take the form
